The Surrey Cardiovascular Clinic Podcast

Deciding whether a statin is right for you depends on two things: your measurable cardiovascular risk and how much your cholesterol is actually influenced by diet. Both questions have real answers, and understanding them helps you and your doctor make a more informed, personalised decision together.

Read blog and try our AI companion pack to see how our cardiometabolic clinic might manage your cholesterol.

A new tool on every SCVC article lets you interrogate the evidence behind our advice using your own AI assistant — here is how it works and why it matters.

https://www.scvc.co.uk/news/ask-the-evidence-how-to-use-ai-to-get-real-answers-from-our-cardiovascular-articles/

Men attending a heart clinic rarely come in with just one concern. Erectile dysfunction, prostate health and unexplained weight gain share biological pathways with cardiovascular disease. This article explores why one cardiology clinic built a dedicated men's health service, and what those links mean for patients and GPs.

Read the full article

Insulin resistance often develops silently for years before diabetes or heart disease appears. Discover how modern metabolic assessment, including body composition, visceral fat analysis and targeted blood testing, can identify early risk, allowing personalised lifestyle and medical strategies to restore metabolic health, improve energy, and reduce long-term cardiovascular risk.

Full blog at https://www.scvc.co.uk/diagnostic-and-health-screening/insulin-resistance-metabolic-health/

Body recomposition focuses on reducing visceral fat while preserving muscle mass, offering superior cardiovascular protection compared to traditional weight loss. This approach proves particularly valuable for patients with coronary disease, those starting GLP-1 therapy, and adults over 60 facing age-related muscle loss. 

https://www.scvc.co.uk/cardiovascular-prevention/cardiologist-body-recomposition/

Transoesophageal echocardiography before atrial fibrillation cardioversion prevents stroke by detecting hidden left atrial appendage clots. The greatest risk comes from atrial stunning after rhythm restoration, not existing thrombus. TOE enables safe early intervention.

Read blog

A single episode of atrial fibrillation in patients with a CHA₂DS₂-VASc score ≥2 often leads to a recommendation for lifelong anticoagulation. But is this always necessary? This article explores when exceptions may be reasonable, the importance of rhythm monitoring, and how shared decision-making can guide personalised, safe stroke prevention strategies.

Read blog 

Patients with a low CHA₂DS₂-VASc score are often considered low risk for stroke. However, around cardioversion, this changes. Atrial paresis following restoration of sinus rhythm creates a temporary high-risk period for clot formation, particularly after AF lasting more than 24 hours, making short-term anticoagulation essential even in younger patients.

Read blog

Modern lipid management requires both substantial percentage LDL reduction and achieving low absolute LDL levels. Relative reduction reflects treatment intensity, while absolute LDL determines residual risk. Trials consistently show “lower is better.” Even with good percentage drops, patients may remain undertreated—making combined pharmacological and lifestyle strategies essential to reduce atherogenic exposure and cardiovascular risk.

Read blog

Cardiology for medics podcast series

LDL-C alone may miss important cardiovascular risk. This article explains why ApoB and small dense LDL often better reflect atherosclerotic burden, especially in metabolic disease and high visceral fat. It outlines practical lipid targets by risk category and shows how LDL-C:ApoB ratios can estimate dangerous particle patterns

Read blog 

Cardiology for medics podcast series